Kwesi S Ankai

Recommended Articles

• Teen Battling Lymphoma Uses Her Make-a-Wish to do the Kindest Gesture Ever!

  In November of 2017, 13-year-old Brooklyn Gallagher began experiencing what appeared to be symptoms of an upper respiratory infection. Initially, her mother, Tiffany Divicenzo, thought that it was merely a common cold. However, as Brooklyn’s symptoms began to worsen, her lymph nodes began to swell...

• What Is Dysuria: Causes, Symptoms, and Treatment

  What is dysuria?Dysuria is the medical term for painful urination or discomfort while urinating. This painful, burning sensation is commonly associated with urinary tract infections, which are usually caused by bacteria. Dysuria is also a common symptom of cystitis (inflammation of the bladder) and...

• Real Heroes Wear Scrubs: A Deeper Look into Holistic Nursing

  A video shared by SBS News in November 2017 made an impression on everyone worldwide. A group of Nurses in Pohang, South Korea mightily secured twenty babies in the nursery room during a 5.4 magnitude earthquake in the area. As if an automatic impulse, the nurses grabbed all the bassinets on wheels...

• Causes and Treatments for a Barking Cough

  What is a barking cough?The medical term for a barking cough is croup, which is a viral condition that causes swelling of the upper airways of children, especially those who are younger than 5 years old. It is also described as the inflammation of the larynx and the trachea in children.There are a...

• What are the Causes and Symptoms of Glaucoma?

  Glaucoma is a group of conditions that leads to the impairment of the optic nerve that carries information from the eyes to the brain. It is a progressive condition, which, if not treated, may lead to complete loss of vision. The most common cause of this damage is the increase in the pressure...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...